Evidence map›Paper›PMID 22592317›Full record

ArticleCell death & disease2012

Overexpression of Batf induces an apoptotic defect and an associated lymphoproliferative disorder in mice.

M R Logan, K L Jordan-Williams, S Poston, J Liao, E J Taparowsky

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. BATF represses BIM to sustain tolerant T cells in the periphery.The Journal of experimental medicine · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. BATF3 programs CD8Nature immunology · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

M R LoganDepartment of Biological Sciences, College of Science, Purdue University, West Lafayette, IN 47907-2064, USA.
K L Jordan-Williams
S Poston
J Liao
E J Taparowsky
Purdue University West Lafayette · USCenter for Cancer Research · US

Funding

AP-1 Complexes and Target Gene RegulationR01CA114381 · NCI · PURDUE UNIVERSITY · PI TAPAROWSKY, ELIZABETH J · 2006 to 2010
$1.3M
Indiana Clinical and Translational Science Institute-T32 Program TL1TL1RR025759 · NCRR · INDIANA UNIVERSITY INDIANAPOLIS · PI SHEKHAR, ANANTHA · 2008 to 2011
$710k
PREDOCTORAL TRAINING IN CHEMICAL PHARMACOLOGYT32GM008298 · NIGMS · PURDUE UNIVERSITY WEST LAFAYETTE · PI BORCH, RICHARD F · 1990 to 1999
–
NCI NIH HHS CA114381NCI NIH HHS CA782464NCI NIH HHS R01 CA114381NCRR NIH HHS 5TL1 RR025759NCRR NIH HHS TL1 RR025759NIGMS NIH HHS T32 GM008298NIGMS NIH HHS T32 GM08298
6 · The paper itself

Abstract

Activator protein-1 (AP-1) is a dimeric transcription factor composed of the Jun, Fos and Atf families of proteins. Batf is expressed in the immune system and participates in AP-1 dimers that modulate gene expression in response to a variety of stimuli. Transgenic (Tg) mice overexpressing human BATF in T cells were generated using the human CD2 promoter (CD2-HA (hemagglutinin antigen) - BATF). By 1 year of age, over 90% of the mice developed a lymphoproliferative disorder (LPD). The enlarged lymph nodes characteristic of this LPD contain a polyclonal accumulation of T cells with a CD4(+) bias, yet efforts to propagate these tumor cells in vitro demonstrate that they do not proliferate as well as wild-type CD4(+) T cells. Instead, the accumulation of these cells is likely due to an apoptotic defect as CD2-HA-BATF Tg T cells challenged by trophic factor withdrawal in vitro resist apoptosis and display a pro-survival pattern of Bcl-2 family protein expression. As elevated levels of Batf expression are a feature of lymphoid tumors in both humans and mice, these observations support the use of CD2-HA-BATF mice as a model for investigating the molecular details of apoptotic dysregulation in LPD.

Indexed as

ApoptosisAnimalsBasic-Leucine Zipper Transcription FactorsCaspase 3CD2 AntigensDisease Models, AnimalHemagglutininsHumansLymphoproliferative DisordersMiceMice, Inbred C57BLMice, TransgenicPromoter Regions, GeneticProto-Oncogene Proteins c-bcl-2T-LymphocytesTranscription Factor AP-1Basic-Leucine Zipper Transcription FactorsBATF protein, humanCaspase 3CD2 AntigensHemagglutininsProto-Oncogene Proteins c-bcl-2Transcription Factor AP-1

Identifiers

PMID22592317
PMCPMC3366083
OpenAlexW1970276518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.